RESEARCHER PROFILE

Lei Chen

← Back to Sun Yat-sen University

L

Sun Yat-sen University

Head and Neck Cancer StudiesHead and Neck Surgical OncologyEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersCancer-related molecular mechanisms research

Lei Chen works in Head and Neck Cancer Studies, Head and Neck Surgical Oncology, Esophageal Cancer Research and Treatment, Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research. Recorded institutional associations include Jiangsu University, Merck & Co., Inc., Rahway, NJ, USA (United States), Shandong University.

907Publications
29,325Citations
71H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

    2016 · 950 citations

  2. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

    2019 · 927 citations

  3. How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?

    2010 · 611 citations

  4. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

    2011 · 558 citations

  5. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

    2018 · 558 citations

  6. Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma

    2019 · 327 citations

  7. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis

    2012 · 293 citations

  8. Re-Evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging

    2009 · 290 citations

  9. Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial

    2019 · 251 citations

  10. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

    2021 · 232 citations

  11. Proposed modifications and incorporation of plasma Epstein‐Barr virus DNA improve the TNM staging system for Epstein‐Barr virus‐related nasopharyngeal carcinoma

    2018 · 215 citations

  12. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

    2024 · 196 citations

  13. The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients

    2020 · 192 citations

  14. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era

    2017 · 190 citations

  15. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma

    2022 · 189 citations

  16. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy

    2016 · 184 citations

  17. Progress report of a randomized trial comparing long‐term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China

    2013 · 166 citations

  18. Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

    2018 · 161 citations

  19. Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial

    2022 · 161 citations

  20. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

    2021 · 156 citations

  21. The evolution of nasopharyngeal carcinoma staging

    2019 · 153 citations

  22. Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial

    2017 · 142 citations

  23. Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation

    2012 · 126 citations

  24. Extension of Local Disease in Nasopharyngeal Carcinoma Detected by Magnetic Resonance Imaging: Improvement of Clinical Target Volume Delineation

    2009 · 116 citations

  25. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China

    2011 · 113 citations

← Return to the university profile